abstract |
The present invention relates to new biologically active derivatives of glutarimides of the general formula (I) or their pharmaceutically acceptable salts, their use as agents for the treatment of eosinophilic diseases, mainly of allergic nature, in particular, asthma, allergic rhinitis, polypous rhinosinusopathy, eosinophilic colitis, eosinophilic syndrome , allergic conjunctivitis, atopic dermatitis, Cherzha-Strauss syndrome, anaphylactic shock, angioedema, eosinophilic vasculitis, eosinophism ceiling elements esophagitis, eosinophilic gastroenteritis, fibroses, pharmaceutical compositions containing glutarimide derivatives of general formula (I). |